OPKO HEALTH, INC. 8-K

What Happened

• On April 28, 2026, OPKO Health, Inc. issued a press release announcing operating and financial highlights for the quarter ended March 31, 2026. The release (attached as Exhibit 99.1 to the 8‑K) includes information on how to access a conference call where management will provide a business update, discuss first-quarter 2026 results, and give financial guidance. The 8‑K was signed by Adam Logal, Senior Vice President and Chief Financial Officer, on April 28, 2026. The press release is furnished, not “filed,” under Section 18 of the Exchange Act.

Key Details

• Press release dated April 28, 2026 covering quarter ended March 31, 2026 (Exhibit 99.1).
• Conference call to discuss Q1 2026 operating and financial results and to provide financial guidance; access details are in the press release.
• Filing made under Item 2.02 (Results of Operations and Financial Condition); exhibit included under Item 9.01.
• 8‑K signed by CFO Adam Logal on April 28, 2026; information furnished (not subject to Section 18 liability).

Why It Matters

• The filing notifies investors that OPKO will disclose its latest quarterly results and forward-looking guidance—key inputs for assessing earnings, revenue trends, and near-term outlook. Retail investors should read the attached press release and consider listening to the conference call for the actual figures and management commentary, since the 8‑K itself furnishes the release but does not include the detailed numeric results in the filing text.